Skip to content

Author

Tara DeYampert

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study.

BACKGROUND Safe and effective antiretroviral options are needed for neonates exposed to HIV-1, but data supporting dolutegravir use from birth are scarce. The aim of this study was to evaluate dolutegravir pharmacokinetics, safety, and tolerability in term neonates, and to identify an appropriate dosing regimen. METH...

J. Momper, Jia-Jia Wang, Sarah Bradford et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.